Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 7,178 | 5,806 | 6,081 | 6,145 | 5,978 |
| Income taxes - deferred | -807 | 320 | -6,262 | -941 | -3,237 |
| Accounts receivable | 10,544 | -1,677 | -8,236 | 4,430 | -3,505 |
| Other Working Capital | 5,843 | 2,341 | -15,262 | 4,730 | 182 |
| Other Operating Activity | 1,276 | 11,924 | 22,235 | -15,544 | 5,620 |
| Operating Cash Flow | $24,034 | $18,714 | $-1,444 | $-1,180 | $5,038 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -183 | -50 | -61 | -97 | -118 |
| Net Acquisitions | -3,275 | -3,212 | -1,359 | -482 | -952 |
| Purchase Sale Intangibles | -2,543 | -216 | -301 | -7,617 | -10,637 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 3 |
| Investing Cash Flow | $-6,001 | $-3,478 | $-1,721 | $-8,196 | $-11,704 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -39,000 | N/A | N/A | N/A |
| Debt Issued | 0 | 17,584 | 35,457 | 3,893 | 350 |
| Debt Repayment | -14,236 | -4,988 | -24,724 | -164 | -369 |
| Common Stock Issued | 19,162 | 7,606 | N/A | 0 | 22,635 |
| Other Financing Activity | -4,130 | -4,250 | -4,328 | -3,066 | -3,933 |
| Financing Cash Flow | $796 | $-23,048 | $6,405 | $663 | $18,683 |
| Exchange Rate Effect | -111 | -2 | -189 | 27 | 1,454 |
| Beginning Cash Position | 5,255 | 13,069 | 10,018 | 18,704 | 5,233 |
| End Cash Position | 23,973 | 5,255 | 13,069 | 10,018 | 18,704 |
| Net Cash Flow | $18,829 | $-7,812 | $3,240 | $-8,713 | $12,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,034 | 18,714 | -1,444 | -1,180 | 5,038 |
| Capital Expenditure | -2,726 | -266 | -362 | -7,714 | -10,755 |
| Free Cash Flow | 21,308 | 18,448 | -1,806 | -8,894 | -5,717 |